Establishing core services for safe research on infectious diseases
Biocontainment Research Support Service(s) Core-Optional
This study is all about improving how scientists at the University of Alabama at Birmingham use advanced tools to better understand and treat infectious diseases, which could help patients by leading to new treatments and better ways to prepare for future outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10910223 on NIH RePORTER |
What this research studies
This research focuses on creating integrated core services at the University of Alabama at Birmingham to support safe and efficient use of advanced scientific equipment for studying infectious diseases. It includes six specialized cores that will handle tasks such as maintaining cell lines, culturing microorganisms, and conducting high-resolution imaging. The project aims to enhance pandemic preparedness by developing medical countermeasures and conducting high containment research with clinical samples. Patients may benefit from the advancements in understanding and treating infectious diseases that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases or those involved in clinical trials related to pandemic preparedness.
Not a fit: Patients with non-infectious conditions or those not involved in clinical research related to infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medical countermeasures and treatments for infectious diseases, enhancing public health responses.
How similar studies have performed: Other research initiatives focused on integrated core services for infectious disease research have shown promise, indicating that this approach could yield significant advancements.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Leal, Sixto Manuel — University of Alabama at Birmingham
- Study coordinator: Leal, Sixto Manuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.